Reading Time: 2 minutes Titan Pharmaceuticals, Inc.(NASDAQ: TTNP), a company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura™ long-term, continuous drug delivery technology, today announced that it will host […]